2019
DOI: 10.1007/978-3-030-17938-0_44
|View full text |Cite
|
Sign up to set email alerts
|

Graph Model for the Identification of Multi-target Drug Information for Culinary Herbs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…They provide alternatives to error prone and time consuming exercises to gather results from multiple sources, which may involve one or many of the tasks like cross referencing across web services, manual browsing, performing federated queries across databases, etc. Many such projects exist ( [19,20,15,21,22,23] ) and, like CompoundDB4j, provide a comprehensive data-centered integration to provide methods to collate and analyze data sources of disparate provenance and storage formats. Deriving from the above, we have developed an ordered network of wellconnected data built on a single graph database to discover synergies between the following entities: Compounds (drugs), Targets, Activities, Assays, Proteins, Pathways, Diseases, Patent Records, Drug Interactions, Metabolites, and Structure Alerts.…”
Section: Introductionmentioning
confidence: 99%
“…They provide alternatives to error prone and time consuming exercises to gather results from multiple sources, which may involve one or many of the tasks like cross referencing across web services, manual browsing, performing federated queries across databases, etc. Many such projects exist ( [19,20,15,21,22,23] ) and, like CompoundDB4j, provide a comprehensive data-centered integration to provide methods to collate and analyze data sources of disparate provenance and storage formats. Deriving from the above, we have developed an ordered network of wellconnected data built on a single graph database to discover synergies between the following entities: Compounds (drugs), Targets, Activities, Assays, Proteins, Pathways, Diseases, Patent Records, Drug Interactions, Metabolites, and Structure Alerts.…”
Section: Introductionmentioning
confidence: 99%